Our groundbreaking approach combines drug delivery systems with advanced lens designs, offering a non-surgical alternative to treating a variety of eye conditions. By embedding therapeutic agents into disposable contact lenses, the company aims to boost patient compliance, drug efficacy, and reduce side effects.
Diopter Technologies holds a strong intellectual property foundation. They are inviting investors and collaborators to help reshape the future of ophthalmology and improve the lives of millions of patients globally.